HealthFirst Talks: COVID-19 Trends: Facts, Misinformation and Late-Breaking News

With vaccines rolling out around the globe, the “end” of the COVID-19 pandemic may be in sight – but there are still plenty of hot topics to tackle in exploring how the world has responded and shifted in the wake of this uncertain era.

On this episode of HealthFirst Talks, Dr. Scott A. Cohen of the Bassett Healthcare Network and infection prevention specialist Dr. Fiona Collins acted as expert panelists, sharing their front-line insights about the faces, misinformation and late-breaking news surrounding what many hope will prove the pandemic’s closing chapter.

One of the central issues surrounds the vaccines, themselves. Many people are unsure about the vaccines’ safety or efficacy, particularly since those available were accelerated through the approval pipeline so quickly. There are also lingering questions about which vaccine is “better” and how they differ.

Cohen and Collins dove into this topic, explaining how money and a streamlined approval process empowered a vaccine to get into the arms of people more quickly than ever before.

The duo also touched on a range of other topics, such as how the vaccines were actually researched and produced, the practicalities of the rollout and overcoming supply chain challenges, and where the world might go from here both in terms of future vaccines and healthcare, overall.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…